HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Eun-Sun Choi Selected Research

mithramycin A

11/2014Modulation of specificity protein 1 by mithramycin A as a novel therapeutic strategy for cervical cancer.
9/2013Mithramycin A induces apoptosis by regulating the mTOR/Mcl-1/tBid pathway in androgen-independent prostate cancer cells.
1/2013Myeloid cell leukemia-1 is a key molecular target for mithramycin A-induced apoptosis in androgen-independent prostate cancer cells and a tumor xenograft animal model.
4/2011Apoptotic effect of tolfenamic acid in androgen receptor-independent prostate cancer cell and xenograft tumor through specificity protein 1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Eun-Sun Choi Research Topics

Disease

15Neoplasms (Cancer)
11/2014 - 03/2010
6Prostatic Neoplasms (Prostate Cancer)
09/2013 - 04/2011
5Mouth Neoplasms (Oral Cancer)
07/2013 - 01/2010
4Uterine Cervical Neoplasms (Cancer of the Cervix)
11/2014 - 03/2011
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
03/2010 - 01/2010
2Mucoepidermoid Carcinoma
03/2014 - 01/2014
2Neoplastic Cell Transformation
01/2013 - 10/2012
2Colorectal Neoplasms (Colorectal Cancer)
04/2011 - 07/2010
1Botulism
09/2021
1Salivary Gland Neoplasms (Salivary Gland Cancer)
06/2017
1AIDS-Related Complex (ARC)
10/2012
1Colonic Neoplasms (Colon Cancer)
03/2010
1Squamous Cell Carcinoma of Head and Neck
01/2010
1Carcinoma (Carcinomatosis)
01/2010

Drug/Important Bio-Agent (IBA)

11Proteins (Proteins, Gene)FDA Link
11/2014 - 01/2010
4mithramycin AIBA
11/2014 - 04/2011
3Methanol (Carbinol)IBA
04/2014 - 09/2012
3AndrogensIBA
09/2013 - 04/2011
3tolfenamic acidIBA
04/2011 - 07/2010
2DAPIIBA
06/2017 - 07/2013
2Antineoplastic Agents (Antineoplastics)IBA
04/2014 - 07/2013
23,3'-diindolylmethane (diindolylmethane)IBA
09/2011 - 03/2010
2SurvivinIBA
04/2011 - 03/2011
2p38 Mitogen-Activated Protein KinasesIBA
07/2010 - 03/2010
1NeurotoxinsIBA
09/2021
1Annexin A5IBA
06/2017
1SilymarinIBA
06/2017
1Silybin (Lagosa)IBA
06/2017
1Trypan BlueFDA Link
06/2017
1AgarIBA
06/2017
1Proteasome Endopeptidase Complex (Proteasome)IBA
11/2014
1Caspase 8 (Caspase-8)IBA
11/2014
1Cisplatin (Platino)FDA LinkGeneric
11/2014
1CurcuminIBA
03/2014
1fucoidanIBA
01/2014
1Serine (L-Serine)FDA Link
09/2013
1BH3 Interacting Domain Death Agonist ProteinIBA
09/2013
1Growth InhibitorsIBA
09/2013
1Histone Deacetylases (Histone Deacetylase)IBA
07/2013
1Histone Deacetylase InhibitorsIBA
07/2013
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
07/2013
1Imiquimod (Aldara)FDA LinkGeneric
06/2013
1MicroRNAs (MicroRNA)IBA
02/2013
1PolyketidesIBA
01/2013
1ErbB Receptors (EGF Receptor)IBA
10/2012
1Epidermal Growth Factor (EGF)IBA
10/2012
1Phosphotransferases (Kinase)IBA
10/2012
1Apoptosis Regulatory ProteinsIBA
09/2012
1isothiocyanic acidIBA
09/2011
11,1- bis(3'- indolyl)- 1- (4- t- butylphenyl)methaneIBA
09/2011
11,1- bis(3'- indolyl)- 1- (4- biphenyl)methaneIBA
09/2011
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
08/2011
1Death Domain ReceptorsIBA
08/2011
1phenethyl isothiocyanate (PEITC)IBA
08/2011
1RNA (Ribonucleic Acid)IBA
04/2011
1Androgen Receptors (Androgen Receptor)IBA
04/2011
1Messenger RNA (mRNA)IBA
03/2011
1Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
07/2010
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
07/2010
1IsothiocyanatesIBA
03/2010
15,5'-dibromo-1,1-bis(3'-indolyl)methaneIBA
03/2010
1sulforaphaneIBA
01/2010
1EnzymesIBA
01/2010
1sauristolactamIBA
01/2010
1Cyclin-Dependent Kinase Inhibitor p21IBA
01/2010
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
01/2010
1KO 202125IBA
01/2010

Therapy/Procedure

1Therapeutics
11/2014
1Drug Therapy (Chemotherapy)
01/2010